ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents.
Status:
Active, not recruiting
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
The main objective of the trial is to assess impact of maintenance therapy with ODM-201 on
radiographic progression-free survival (rPFS) of patients with mCRPC pretreated with novel
hormonal agents who have non-progressive disease after chemotherapy with a taxane.